Startseite Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects

  • Ingrid M. van Beynum , Christiaan Mooij , Livia Kapusta , Sandra Heil , Martin den Heijer und Henk J. Blom
Veröffentlicht/Copyright: 1. Oktober 2008
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Endothelial nitric oxide synthase (eNOS) produces nitric oxide, which plays a role in vasodilatation and in the regulation of cell growth and apoptosis. eNOS-deficient mice have impaired cardiac development resulting in congenital heart defects (CHDs). In humans, a single nucleotide polymorphism in the gene coding for eNOS (894G>T) is associated with birth defects.

Methods: We investigated the eNOS 894G>T polymorphism in relation to CHDs using a case-control study and a case-parent study. Possible interaction with maternal cigarette smoking during pregnancy and periconceptional folic acid supplementation was also investigated in a case-only approach.

Results: The eNOS 894G>T polymorphism was genotyped in 170 CHD-affected children, in 161 of their mothers, 215 control children and 240 control women. For the case-parent study, 135 complete triads were available. The sum of eNOS 894 GT and TT vs. GG genotypes in children was associated with increased CHD risk [odds ratio, OR 1.5 (95% CI 1.03–2.31)]. There was no preferential transmission of the 894T allele [OR 1.2 (95% CI 0.81–1.69)]. Overall, the maternal eNOS 894 GT or TT vs. GG genotypes were not associated with increased CHD risk. The maternal 894TT genotype in combination with maternal smoking was associated with an increased risk, particularly for a subgroup of other than conotruncal heart defects [OR 3.3 (95% CI 1.00–11.1)]. No interaction with periconceptional folic acid supplementation was observed.

Conclusions: Our data indicate that the eNOS 894G>T polymorphism is associated with increased CHD risk. The study also provides evidence of a possible gene-environment interaction effect on CHD risk between the maternal eNOS 894G>T variant and maternal cigarette smoking during pregnancy. This observation should be interpreted with caution because of the relatively small subgroups. Further study in a larger group of CHD subjects is required.

Clin Chem Lab Med 2008;46:1369–75.


Corresponding author: I.M. van Beynum, Children's Heart Center, Radboud University Nijmegen Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands Phone: +31-24-3619060, Fax: +31-24-3619052,

Received: 2008-3-20
Accepted: 2008-6-10
Published Online: 2008-10-01
Published in Print: 2008-10-01

©2008 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Review
  2. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis
  3. Minireview
  4. Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children?
  5. Genetics and Molecular Diagnostics
  6. Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients
  7. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects
  8. New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia
  9. Enzyme-free signal amplification of analyte in a single closed tube by fluorescent hybridization chain reaction
  10. Five X-chromosome short tandem repeats in a Western Mexican population
  11. General Clinical Chemistry and Laboratory Medicine
  12. Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis
  13. Methionine metabolism in an animal model of sepsis
  14. Hypochlorous acid is a potent inactivator of human plasminogen at concentrations secreted by activated granulocytes
  15. Association of serum γ-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults
  16. Immunoradiometric determination of thyroglobulin in serum samples by time calibration transfer
  17. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients
  18. Measurement of 10,11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography
  19. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population
  20. Reference Values and Biological Variations
  21. Analytical quality goals for parathyroid hormone based on biological variation
  22. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation
  23. Validation and Outcome Studies
  24. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard
  25. An expert system for the classification of serum protein electrophoresis patterns
  26. Impact of a satellite laboratory on turnaround times for the emergency department
  27. Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins
  28. Guidelines and Recommendations
  29. Protein standardization V: value transfer. A practical protocol for the assignment of serum protein values from a Reference Material to a Target Material
  30. Letter to the Editor
  31. Biological variability evaluation and comparison of three different methods for C-peptide measurement
  32. Abstracts
  33. 10.1515/CCLM.2008.361
Heruntergeladen am 14.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.271/html
Button zum nach oben scrollen